The Omicron vaccine will be approved by Health Canada on Thursday

Health Canada will on Thursday approve a revised version of Moderna’s COVID-19 vaccine targeting the Omicron variant, which has been confirmed The press.

Updated yesterday at 5:01pm.

Alice Girard bosses

Alice Girard bosses
The press

Henri Ouellette-Vezina

Henri Ouellette-Vezina
The press

Twenty-four hours after the United States on Thursday, Ottawa will confirm it will give the green light to administer a new generation of anti-COVID-19 vaccines it says are bivalent. This new version targets both the original strain of the coronavirus and the subvariant Omicron BA.1. Delivery and availability details will be announced at a later date.

The COVID-19 vaccines currently available in Canada are designed to target only the original strain of the virus. Since the beginning of the pandemic, however, the virus has continued to mutate and is proving to be more adept at immune escape.

Moderna submitted its request for this new generation of vaccines to Health Canada on June 30.

12 million doses

The possibility of a bivalent vaccine considered more “resistant” to the Omicron vaccine and its many sub-variants has been debated around the world for several months. In Canada, Ottawa has already announced it has secured nearly 12 million doses of the new bivalent vaccine for a first shipment. Of those, 2.7 million should return to Quebec, below the proportion of Canada’s population, the Department of Health and Human Services (MSSS) specified on Wednesday.

Last week, with fears of an increase in the spread of COVID-19 at the start of the school year, Quebec’s public health department also anticipated the vaccination campaign for all 18 years and older. Since last Wednesday, they can make an appointment to get a booster shot if it’s been more than five months since their last dose.

The then State Director for Public Health, Dr.right Luc Boileau had claimed that the vaccine adapted to Omicron should be available in Quebec “within less than two weeks”.

“When the new vaccine arrives, we will exchange it for the new vaccine. We will not sell the stocks we have of the current vaccine,” Mr Boileau also stated. At her side, the microbiologist-infectiologist and President of the Committee for Immunization in Québec (CIQ), the DD However, Caroline Quach had warned that this bivalent vaccine would only be available to people aged 18 and over for the time being. The youngest will have to make do with the current vaccine for now, she added.

In mid-August, Federal Public Health pledged to “work as quickly as possible” to approve the new vaccines adapted to Moderna and Pfizer Pharmaceuticals’ Omicron, ruling that at the start of a possible eighth wave of COVID-19 in this A booster vaccination with the current vaccine has “top priority” in autumn.

With Agence France-Presse (AFP) and The Canadian Press

Leave a Comment